Phathom Pharmaceuticals Inc (PHAT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.41 +0.19 (+4.50%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.45 +0.04 (+0.91%) 18:25 ET
for Fri, Mar 14th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -334,326 | -201,592 | -197,723 | -143,883 | -129,068 |
| Depreciation Amortization | 2,987 | 2,452 | 2,730 | 4,116 | 1,596 |
| Accounts receivable | -37,160 | -1,637 | N/A | N/A | N/A |
| Other Working Capital | -15,298 | -13,644 | 5,438 | -27,315 | 51,717 |
| Other Operating Activity | 117,027 | 76,841 | 43,025 | 18,625 | 6,067 |
| Operating Cash Flow | $-266,770 | $-137,580 | $-146,530 | $-148,457 | $-69,688 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -135 | -1,634 | -1,041 | -328 | -1,040 |
| Investing Cash Flow | $-135 | $-1,634 | $-1,041 | $-328 | $-1,040 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 59,400 | 39,318 | N/A | 96,889 | 25,000 |
| Debt Repayment | N/A | N/A | N/A | -54,125 | N/A |
| Common Stock Issued | 123,374 | 155,587 | 24,596 | 1,944 | 89,459 |
| Other Financing Activity | 0 | 172,675 | 95,446 | 0 | 0 |
| Financing Cash Flow | $182,774 | $367,580 | $120,042 | $44,708 | $114,459 |
| Beginning Cash Position | 384,256 | 155,890 | 183,419 | 287,496 | 243,765 |
| End Cash Position | 300,125 | 384,256 | 155,890 | 183,419 | 287,496 |
| Net Cash Flow | $-84,131 | $228,366 | $-27,529 | $-104,077 | $43,731 |
| Free Cash Flow | |||||
| Operating Cash Flow | -266,770 | -137,580 | -146,530 | -148,457 | -69,688 |
| Capital Expenditure | -135 | -1,634 | -1,041 | -328 | -1,040 |
| Free Cash Flow | -266,905 | -139,214 | -147,571 | -148,785 | -70,728 |